Home
Our Focus
- Overview
- Literature & Publications
Pipeline
Clinical Trials
ReMEDy2 Trial
About DiaMedica
- Overview
- Leadership
- Careers
- Contact
Investors Relations

Events & Presentations

Investors Relations

Investors Relations

Overview
Press Releases
Events & Presentations
Stock Data
Analyst Coverage
Financial Reports & SEC Filings
Governance
Resources

Conference Call to Discuss Interim Phase 2 Preeclampsia Results

Jul 17, 2025 4:30 pm EDT

Webcast

Email Alerts
Contacts
RSS News Feed

© 2025 DiaMedica Therapeutics, Inc. All Rights Reserved.

Twitter LinkedIn

Privacy Policy Disclaimer Sitemap